CXCR4 and myocardial infarction: Indeed, our data here showed that the CXCR4+ subpopulation of iCS derived cells (iCSDC) delivered by intravenous injection had similar therapeutic effects with intramyocardial injection on the mouse model of MI, representing a safer delivery approach.